Coronary artery disease (CAD) may be associated with the risk of deficiency of the following vital nutrients (micronutrients):
- Trace element selenium
Within the framework of micronutrient medicine (vital substances), the following vital substances (micronutrients) are used to prevent CHD:
- Vitamins B6, B12, C and folic acid.
- Mineral magnesium
- Omega-3 fatty acids docosahexaenoic acid and eicosapentaenoic acid
- Isoflavones genistein, daidzein, glycitein; flavonoids hesperitin and naringenin, lycopene.
- Dietary fiber
In the context of micronutrient medicine (vital substances), the following vital substances (micronutrients) are used for supportive therapy of CHD:
- Vitamins C, E, beta-carotene, vitamins B6, B12 and folic acid.
- Omega-3 fatty acids: omega-3 eicosapentaenoic acid, omega-3 docosahexaenoic acid.
- L-Carnitine
The above vital substance recommendations were created with the help of medical experts. All statements are supported by scientific studies with high levels of evidence. For a therapy recommendation, only clinical studies with the highest degrees of evidence (grade 1a/1b and 2a/2b) were used, which due to their high significance prove the therapy recommendation.
* Vital substances include vitamins, minerals, trace elements, vital amino acids, vital fatty acids, etc.
